Literature DB >> 17244900

Efficacy of continuous intra-articular bupivacaine infusion for postoperative analgesia after anterior cruciate ligament reconstruction: a double-blinded, placebo-controlled, prospective, and randomized study.

Richard D Parker1, Kathleen Streem, Leah Schmitz, Paul A Martineau.   

Abstract

BACKGROUND: The increasing trend toward outpatient surgery has stimulated the development of techniques focused on decreasing perioperative and postoperative pain. Pain control infusion pumps are gaining in popularity in orthopaedic procedures to control postoperative pain. HYPOTHESIS: Continuous infusion of bupivacaine via a catheter placed intra-articular into the knee after anterior cruciate ligament reconstruction using ipsilateral autograft quadrupled semitendinosus will decrease postoperative pain scores and narcotic and NSAID consumption. STUDY
DESIGN: Randomized controlled trial; Level of evidence, 1.
METHODS: Three randomized study groups of 21 subjects were evaluated: group I, 0.25% bupivacaine infused intra-articular at 4 mL/hour for 72 hours (study); Group II, 0.9% saline infused intra-articular at 4 mL/hr for 72 hours (placebo); Group III, no intra-articular infusion catheter (control). Each subject received general anesthesia and preemptive intra-articular anesthesia. Visual analog scale pain scores and analgesic use were compiled for the 96-hour study period.
RESULTS: With the exception of significantly higher total narcotic usage in the control group compared with the study group only for the time period of 48 to 72 hours, there were no other statistically significant differences between each of the study groups with respect to pain and narcotic and NSAID use for the entire study period.
CONCLUSION: The continuous infusion of intra-articular bupivacaine via pain control infusion pumps after anterior cruciate ligament reconstruction using ipsilateral autograft quadrupled semitendinosus cannot be supported when postoperative visual analog scale pain scores and analgesic use are the rationale for justification.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244900     DOI: 10.1177/0363546506296313

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  6 in total

1.  Comparison of intra-articular low-dose sufentanil, ropivacaine, and combined sufentanil and ropivacaine on post-operative analgesia of isolated anterior cruciate ligament reconstruction.

Authors:  Xin Wang; Donglin Jia; Xiuyun Chen; Yan Xu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-12-08       Impact factor: 4.342

2.  Intra-articular morphine and bupivicaine for post-operative analgesia in anterior cruciate ligament reconstruction: a prospective randomised controlled trial.

Authors:  S Senthilkumaran; R Tate; J R M Read; A G Sutherland
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-09-19       Impact factor: 4.342

Review 3.  Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs.

Authors:  Antje Barreveld; Jürgen Witte; Harkirat Chahal; Marcel E Durieux; Gary Strichartz
Journal:  Anesth Analg       Date:  2013-02-13       Impact factor: 5.108

4.  Evaluation of analgesic efficacy of dexmedetomidine as adjuvant with ropivacaine in ultrasound-guided adductor canal block in patients following anterior cruciate ligament reconstruction surgeries.

Authors:  Deepak Thapa; Vanita Ahuja; Khushboo Pandey; Satinder Gombar; Ravi Gupta
Journal:  Br J Pain       Date:  2018-08-30

5.  Immediate post-operative pain in anterior cruciate ligament reconstruction surgery with bone patellar tendon bone graft versus hamstring graft.

Authors:  Ravi Gupta; Dheeraj Kapoor; Love Kapoor; Anubhav Malhotra; Gladson David Masih; Anil Kapoor; Shweta Joshi
Journal:  J Orthop Surg Res       Date:  2016-06-08       Impact factor: 2.359

Review 6.  Continuous Local Infiltration Analgesia for Pain Control After Total Knee Arthroplasty: A Meta-analysis of Randomized Controlled Trials.

Authors:  Xiao-Lei Sun; Zhi-Hu Zhao; Jian-Xiong Ma; Feng-Bo Li; Yan-Jun Li; Xin-Min Meng; Xin-Long Ma
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.